{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:10:46Z","timestamp":1789726246180,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1038\/s41390-023-02591-5","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T14:02:28Z","timestamp":1685109748000},"page":"1600-1608","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and safety of macrolides in the treatment of children with bronchiectasis: a meta-analysis"],"prefix":"10.1038","volume":"94","author":[{"given":"Guihua","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weigang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"key":"2591_CR1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/ppul.23380","volume":"51","author":"V Goyal","year":"2016","unstructured":"Goyal, V., Grimwood, K., Marchant, J., Masters, I. B. & Chang, A. B. Pediatric bronchiectasis: no longer an orphan disease. Pediatr. Pulmonol. 51, 450\u2013469 (2016).","journal-title":"Pediatr. Pulmonol."},{"key":"2591_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fped.2017.00027","volume":"5","author":"GB McCallum","year":"2017","unstructured":"McCallum, G. B. & Binks, M. J. The epidemiology of chronic suppurative lung disease and bronchiectasis in children and adolescents. Front. Pediatr. 5, 27 (2017).","journal-title":"Front. Pediatr."},{"issue":"Suppl 1","key":"2591_CR3","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/thx.2010.136119","volume":"65","author":"MC Pasteur","year":"2010","unstructured":"Pasteur, M. C., Bilton, D. & Hill, A. T. British Thoracic Society Non-CF Bronchiectasis Guideline Group. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 65(Suppl 1), i1\u2013i58 (2010).","journal-title":"Thorax"},{"key":"2591_CR4","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1164\/rccm.201303-0411CI","volume":"188","author":"PJ McShane","year":"2013","unstructured":"McShane, P. J., Naureckas, E. T., Tino, G. & Strek, M. E. Non-cystic fibrosis bronchiectasis. Am. J. Respir. Crit. Care Med. 188, 647\u2013656 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2591_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/ppul.24252","volume":"54","author":"P El Boustany","year":"2019","unstructured":"El Boustany, P. et al. A review of non-cystic fibrosis bronchiectasis in children with a focus on the role of long-term treatment with macrolides. Pediatr. Pulmonol. 54, 487\u2013496 (2019).","journal-title":"Pediatr. Pulmonol."},{"key":"2591_CR6","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1136\/adc.2004.066472","volume":"90","author":"J Twiss","year":"2005","unstructured":"Twiss, J., Metcalfe, R., Edwards, E. & Byrnes, C. New Zealand national incidence of bronchiectasis \u201ctoo high\u201d for a developed country. Arch. Dis. Child 90, 737\u2013740 (2005).","journal-title":"Arch. Dis. Child"},{"key":"2591_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1513\/AnnalsATS.201406-257OC","volume":"12","author":"L Das","year":"2015","unstructured":"Das, L. & Kovesi, T. A. Bronchiectasis in children from Qikiqtani (Baffin) Region, Nunavut, Canada. Ann. Am. Thorac. Soc. 12, 96\u2013100 (2015).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"2591_CR8","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1378\/chest.11-0679","volume":"141","author":"N Kapur","year":"2012","unstructured":"Kapur, N., Masters, I. B., Newcombe, P. & Chang, A. B. The burden of disease in pediatric non-cystic fibrosis bronchiectasis. Chest 141, 1018\u20131024 (2012).","journal-title":"Chest"},{"key":"2591_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ppul.21331","volume":"46","author":"KA Munro","year":"2011","unstructured":"Munro, K. A. et al. Do New Zealand children with non-cystic fibrosis bronchiectasis show disease progression? Pediatr. Pulmonol. 46, 131\u2013138 (2011).","journal-title":"Pediatr. Pulmonol."},{"key":"2591_CR10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1378\/chest.09-2932","volume":"138","author":"N Kapur","year":"2010","unstructured":"Kapur, N., Masters, I. B. & Chang, A. B. Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis: what influences lung function stability? Chest 138, 158\u2013164 (2010).","journal-title":"Chest"},{"key":"2591_CR11","first-page":"1","volume":"74","author":"AT Hill","year":"2019","unstructured":"Hill, A. T. et al. British Thoracic Society Guideline for bronchiectasis in adults. Thorax 74, 1\u201369 (2019).","journal-title":"Thorax"},{"key":"2591_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/jcm5120115","volume":"5","author":"JK Khoo","year":"2016","unstructured":"Khoo, J. K., Venning, V., Wong, C. & Jayaram, L. Bronchiectasis in the last five years: new developments. J. Clin. Med. 5, 115 (2016).","journal-title":"J. Clin. Med."},{"key":"2591_CR13","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.rmed.2014.09.005","volume":"108","author":"CS Haworth","year":"2014","unstructured":"Haworth, C. S., Bilton, D. & Elborn, J. S. Long-term macrolide maintenance therapy in non-CF bronchiectasis: evidence and questions. Respir. Med. 108, 1397\u20131408 (2014).","journal-title":"Respir. Med."},{"key":"2591_CR14","doi-asserted-by":"publisher","first-page":"584262","DOI":"10.1155\/2012\/584262","volume":"2012","author":"HC Steel","year":"2012","unstructured":"Steel, H. C., Theron, A. J., Cockeran, R., Anderson, R. & Feldman, C. Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics. Mediators Inflamm. 2012, 584262 (2012).","journal-title":"Mediators Inflamm."},{"key":"2591_CR15","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1136\/thoraxjnl-2019-213929","volume":"75","author":"D Smith","year":"2020","unstructured":"Smith, D. et al. British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease. Thorax 75, 370\u2013404 (2020).","journal-title":"Thorax"},{"key":"2591_CR16","doi-asserted-by":"publisher","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","volume":"50","author":"E Polverino","year":"2017","unstructured":"Polverino, E. et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur. Respir. J. 50, 1700629 (2017).","journal-title":"Eur. Respir. J."},{"key":"2591_CR17","doi-asserted-by":"publisher","first-page":"2002990","DOI":"10.1183\/13993003.02990-2020","volume":"58","author":"AB Chang","year":"2021","unstructured":"Chang, A. B. et al. European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis. Eur. Respir. J. 58, 2002990 (2021).","journal-title":"Eur. Respir. J."},{"key":"2591_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5694\/mja14.00287","volume":"202","author":"AB Chang","year":"2015","unstructured":"Chang, A. B. et al. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines. Med. J. Aust. 202, 21\u201323 (2015).","journal-title":"Med. J. Aust."},{"key":"2591_CR19","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S2213-2600(19)30191-2","volume":"7","author":"JD Chalmers","year":"2019","unstructured":"Chalmers, J. D. et al. Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis. Lancet Respir. Med. 7, 845\u2013854 (2019).","journal-title":"Lancet Respir. Med."},{"key":"2591_CR20","doi-asserted-by":"publisher","first-page":"e15285","DOI":"10.1097\/MD.0000000000015285","volume":"98","author":"D Wang","year":"2019","unstructured":"Wang, D., Fu, W. & Dai, J. Meta-analysis of macrolide maintenance therapy for prevention of disease exacerbations in patients with noncystic fibrosis bronchiectasis. Medicine (Baltimore) 98, e15285 (2019).","journal-title":"Medicine (Baltimore)"},{"key":"2591_CR21","first-page":"CD012406","volume":"3","author":"C Kelly","year":"2018","unstructured":"Kelly, C. et al. Macrolide antibiotics for bronchiectasis. Cochrane Database Syst. Rev. 3, CD012406 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2591_CR22","doi-asserted-by":"crossref","unstructured":"PRISMA 2020. J. Clin. Epidemiol. 134, A5\u2013A6 (2021).","DOI":"10.1016\/j.jclinepi.2021.04.008"},{"key":"2591_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.pedhc.2021.04.011","volume":"35","author":"MK Swartz","year":"2021","unstructured":"Swartz, M. K. PRISMA 2020: an Update. J. Pediatr. Health Care 35, 351 (2021).","journal-title":"J. Pediatr. Health Care"},{"key":"2591_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/0253-7184.69003","volume":"31","author":"S Aslam","year":"2010","unstructured":"Aslam, S. & Emmanuel, P. Formulating a researchable question: a critical step for facilitating good clinical research. Indian J. Sex. Transm. Dis. AIDS 31, 47\u201350 (2010).","journal-title":"Indian J. Sex. Transm. Dis. AIDS"},{"key":"2591_CR25","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne, J. A. C. et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366, l4898 (2019).","journal-title":"BMJ"},{"key":"2591_CR26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins, J. P., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. BMJ 327, 557\u2013560 (2003).","journal-title":"BMJ"},{"key":"2591_CR27","unstructured":"Higgins, J. P. T. et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (Cochrane Collaboration, London, 2020)."},{"key":"2591_CR28","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/S0140-6736(18)31723-9","volume":"392","author":"V Goyal","year":"2018","unstructured":"Goyal, V. et al. Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial. Lancet 392, 1197\u20131206 (2018).","journal-title":"Lancet"},{"key":"2591_CR29","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S2213-2600(19)30254-1","volume":"7","author":"V Goyal","year":"2019","unstructured":"Goyal, V. et al. Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial. Lancet Respir. Med. 7, 791\u2013801 (2019).","journal-title":"Lancet Respir. Med."},{"key":"2591_CR30","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/s10096-015-2480-0","volume":"34","author":"KM Hare","year":"2015","unstructured":"Hare, K. M. et al. Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo. Eur. J. Clin. Microbiol. Infect. Dis. 34, 2275\u20132285 (2015).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"2591_CR31","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S2213-2600(13)70185-1","volume":"1","author":"PC Valery","year":"2013","unstructured":"Valery, P. C. et al. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial. lancet Respir. Med. 1, 610\u2013620 (2013).","journal-title":"lancet Respir. Med."},{"key":"2591_CR32","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1183\/09031936.97.10050994","volume":"10","author":"YY Koh","year":"1997","unstructured":"Koh, Y. Y., Lee, M. H., Sun, Y. H., Sung, K. W. & Chae, J. H. Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study. Eur. Respir. J. 10, 994\u2013999 (1997).","journal-title":"Eur. Respir. J."},{"key":"2591_CR33","first-page":"044","volume":"5","author":"R Masekela","year":"2013","unstructured":"Masekela, R. et al. Lack of efficacy of an immunomodulatory macrolide in childhood HIV related bronchiectasis: a randomised, placebo-controlled trial. J. Antivir. Antiretrovir. 5, 044\u2013049 (2013).","journal-title":"J. Antivir. Antiretrovir."},{"key":"2591_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1365-2710.2006.00708.x","volume":"31","author":"E Yal\u00e7in","year":"2006","unstructured":"Yal\u00e7in, E. et al. Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis. J. Clin. Pharm. Ther. 31, 49\u201355 (2006).","journal-title":"J. Clin. Pharm. Ther."},{"key":"2591_CR35","doi-asserted-by":"publisher","first-page":"1010016","DOI":"10.3389\/fped.2022.1010016","volume":"10","author":"KA Ramsey","year":"2022","unstructured":"Ramsey, K. A. & Schultz, A. Monitoring disease progression in childhood bronchiectasis. Front. Pediatr. 10, 1010016 (2022).","journal-title":"Front. Pediatr."},{"key":"2591_CR36","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/qjmed\/hct109","volume":"106","author":"MJ McDonnell","year":"2013","unstructured":"McDonnell, M. J., Ward, C., Lordan, J. L. & Rutherford, R. M. Non-cystic fibrosis bronchiectasis. QJM 106, 709\u2013715 (2013).","journal-title":"QJM"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02591-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02591-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02591-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T13:03:29Z","timestamp":1699016609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02591-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["2591"],"URL":"https:\/\/doi.org\/10.1038\/s41390-023-02591-5","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,26]]},"assertion":[{"value":"8 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}